Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aurinia Pharm Ord (AUPH)

Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,179,795
  • Shares Outstanding, K 143,179
  • Annual Sales, $ 175,510 K
  • Annual Income, $ -78,020 K
  • EBIT $ -23 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.45
  • Price/Sales 6.63
  • Price/Cash Flow N/A
  • Price/Book 3.00

Options Overview Details

View History
  • Implied Volatility 51.22% ( +8.51%)
  • Historical Volatility 41.32%
  • IV Percentile 21%
  • IV Rank 18.16%
  • IV High 122.16% on 12/13/23
  • IV Low 35.48% on 10/15/24
  • Put/Call Vol Ratio 0.04
  • Today's Volume 2,798
  • Volume Avg (30-Day) 1,435
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 58,575
  • Open Int (30-Day) 59,514

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.07
  • Number of Estimates 3
  • High Estimate 0.16
  • Low Estimate -0.06
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +136.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.85 +28.03%
on 10/23/24
8.83 -0.68%
on 11/21/24
+1.60 (+22.32%)
since 10/21/24
3-Month
6.42 +36.60%
on 09/11/24
8.83 -0.68%
on 11/21/24
+2.18 (+33.08%)
since 08/21/24
52-Week
4.71 +86.20%
on 04/18/24
9.74 -9.96%
on 12/18/23
+0.03 (+0.34%)
since 11/21/23

Most Recent Stories

More News
10 Stocks Retailers On Stocktwits Are Most Bullish/Bearish About To Start The Week

As the new week unfolds, earnings and economic data will again dictate sentiment.

MARA : 24.18 (+6.85%)
BLK : 1,028.00 (+0.32%)
NFLX : 897.48 (+1.54%)
PDD : 104.09 (-10.64%)
AUPH : 8.77 (+6.43%)
CKPT : 3.47 (+2.66%)
EVH : 11.59 (+2.48%)
EBS : 9.40 (+5.86%)
BIDU : 81.63 (-5.90%)
SPY : 593.67 (+0.54%)
COIN : 295.23 (-7.74%)
Aurinia Pharmaceuticals Soars After Earnings Beat, Strategic Overhaul: Retail Sentiment Turns Extremely Bullish

Aurinia plans to slash 45% of its entire workforce with an aim to save more than $40 million in annual operating expenses.

IWO : 304.85 (+1.82%)
AUPH : 8.77 (+6.43%)
IWM : 234.44 (+1.52%)
Aurinia: Q3 Earnings Snapshot

Aurinia: Q3 Earnings Snapshot

AUPH : 8.77 (+6.43%)
Aurinia: Q2 Earnings Snapshot

Aurinia: Q2 Earnings Snapshot

AUPH : 8.77 (+6.43%)
Why Aurinia Pharmaceuticals Stock Is Slumping Today

The biotech's premium valuation doesn't seem to be sitting well with investors.

AUPH : 8.77 (+6.43%)
Why Aurinia Pharmaceuticals Stock Is Marching Higher Friday

The biotech's board is exploring strategic alternatives to boost shareholder value.

NVS : 103.85 (+0.74%)
BMY : 58.23 (+0.60%)
AUPH : 8.77 (+6.43%)
S&P Futures Climb Ahead of Key U.S. Inflation Data

September S&P 500 futures (ESU23) are trending up +0.33% this morning as market participants awaited a reading on the Federal Reserve’s preferred inflation gauge.

ESU23 : 4,491.72s (-0.32%)
WFC : 74.83 (+1.70%)
JPM : 244.76 (+1.65%)
BAC : 46.46 (+0.87%)
OXY : 51.54 (+1.24%)
MU : 102.76 (+4.46%)
ENGI.P.DX : 15.410 (-0.13%)
NKE : 75.10 (+2.37%)
ACCD : 3.71 (+4.21%)
AUPH : 8.77 (+6.43%)
CCL : 25.35 (+1.08%)
NVDA : 146.67 (+0.53%)
MKT Capital Issues Statement Regarding Aurinia’s Disappointing First Quarter 2023 Financial Results

MKT Capital Ltd. (together with its affiliates, “MKT Capital” or “we”), a significant shareholder of Aurinia Pharmaceuticals, Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) with beneficial...

AUPH : 8.77 (+6.43%)
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for first quarter ended March 31, 2023. Amounts are expressed in U.S. dollars.

AUPH : 8.77 (+6.43%)
ISS Recommends Aurinia Shareholders Vote Against the Company’s Named Executive Officers’ Compensation

MKT Capital Ltd. (together with its affiliates, “MKT Capital” or “we”), a significant shareholder of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) with beneficial...

AUPH : 8.77 (+6.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

See More

Key Turning Points

3rd Resistance Point 9.50
2nd Resistance Point 9.16
1st Resistance Point 8.97
Last Price 8.77
1st Support Level 8.44
2nd Support Level 8.10
3rd Support Level 7.91

See More

52-Week High 9.74
Last Price 8.77
Fibonacci 61.8% 7.82
Fibonacci 50% 7.22
Fibonacci 38.2% 6.63
52-Week Low 4.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar